People's Health Press
ISSN 2096-2738 CN 11-9370/R

Source Journal for Chinese Scientific and Technical Papers and Citations
Source Journal for Annual Report for Chinese Academic Journal Impact Factors(2022)
Indexed Journals in the Database of the Chemical Abstracts Service (CAS), USA
Indexed Journals in the Database of the Japan Science and Technology Agency (JST)

  • Official WeChat

  • Official Weibo

  • Official headlines

Electronic Journal of Emerging Infectious Diseases ›› 2021, Vol. 6 ›› Issue (1): 65-72.doi: 10.19871/j.cnki.xfcrbzz.2021.01.015

• Review • Previous Articles     Next Articles

Pulmonary multi-drug resistant tuberculosis: a radiological review

Ma Luyao1,2, Zheng Qiuting3, Lu Puxuan3, Li Hongjun4, Fleming YM Lure5, Yin Xiaoping1, Guo Lin4   

  1. 1. Clinical Medical College, Hebei University,Hebei Baoding 071000, China;
    2. CT-MRI Room, Affiliated Hospital of Hebei University, Hebei Baoding 071000, China;
    3. Shenzhen Center for Chronic Disease Control,Guangdong Shenzhen 518020, China;
    4. Department of Radiology, Beijing You'an Hospital, Capital Medical University,Beijing 1000689, China;
    5. Shenzhen Zhiying Medical Imaging, Guangdong Shenzhen 518109, China
  • Received:2019-12-15 Online:2021-02-28 Published:2021-03-03

Abstract: Drug-resistant tuberculosis is a respiratory infectious disease caused by drug-resistant Mycobacterium tuberculosis, which seriously threatens human health. The disease is poorly treated, especially multidrug-resistant tuberculosis (MDR-TB).Therefore, timely detection of MDR-TB can enable patients to be better managed and treated.Based on published literature, this article searches the PubMed database in October 2019. The search keyword combination is "(multidrug-resistant tuberculosis) AND (CT or radiograph or imaging or X-ray or computed tomography)", while searching Wanfang Medical database, the search keyword combination is "(multidrug-resistant tuberculosis) and (CT or radiology or imaging or X-ray)" to analyze and summarize the progress of MDR-TB in imaging research.The published literature shows that MDR-TB patients have no definite chest imaging diagnosis basis. When the chest X-ray and CT, the patient appears lung cavity, especially the larger the cavity or the thicker the cavity wall, the more prompt It is the possibility of MDR-TB, and the imaging doctor should doubt the possibility of MDR-TB when there is the appearance of damaged lung imaging.At the same time, the analysis results show that CT is the main imaging method, and X-rays have certain limitations. Positron Emission Tomography-Computed Tomography (PET-CT) is currently only applicable to assess MDR-TB treatment. The result description is not concise, you can refer to how other similar articles are described. Using artificial intelligence (AI) technology for MDR-TB auxiliary diagnosis will become a new key research direction in the future.

Key words: Tuberculosis, Multidrug-resistant tuberculosis, Computed tomography